Related references
Note: Only part of the references are listed.Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
William M. Pardridge
FRONTIERS IN AGING NEUROSCIENCE (2020)
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer's Disease Mouse Model
Allal Boutajangout et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells
Karin Jennbacken et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
Victor M. Pulgar
FRONTIERS IN NEUROSCIENCE (2019)
Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics
Alessandro Zorzi et al.
MEDCHEMCOMM (2019)
The role of brain barriers in fluid movement in the CNS: is there a 'glymphatic' system?
N. Joan Abbott et al.
ACTA NEUROPATHOLOGICA (2018)
Comparative studies of the serum half-life extension of a protein via site-specific conjugation to a species-matched or -mismatched albumin
Byungseop Yang et al.
BIOMATERIALS SCIENCE (2018)
Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins
Huanbo Tan et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
Mohamed Altai et al.
CELLS (2018)
Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration
Qin Wang et al.
FLUIDS AND BARRIERS OF THE CNS (2018)
The vascular basement membrane in the healthy and pathological brain
Maj S. Thomsen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
An approach for half-life extension and activity preservation of an anti-diabetic peptide drug based on genetic fusion with an albumin-binding aptide
Daejin Kim et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Affibody Molecules in Biotechnological and Medical Applications
Stefan Stahl et al.
TRENDS IN BIOTECHNOLOGY (2017)
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Greta Hultqvist et al.
THERANOSTICS (2017)
Sorting Tubules Regulate Blood-Brain Barrier Transcytosis
Roberto Villasenor et al.
CELL REPORTS (2017)
Iron uptake and transport across physiological barriers
Kari A. Duck et al.
BIOMETALS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Y. Joy Yu Zuchero et al.
NEURON (2016)
A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
Hanna Lindberg et al.
BIOTECHNOLOGY JOURNAL (2015)
Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier
Itsaso Cabezon et al.
MOLECULAR PHARMACEUTICS (2015)
A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
Hanna Lindberg et al.
BIOTECHNOLOGY JOURNAL (2015)
Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli
Daniela Luz et al.
PLOS ONE (2015)
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Nga Bien-Ly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Jens Niewoehner et al.
NEURON (2014)
Immunotherapy for Alzheimer's disease: past, present and future
Brian Spencer et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Multiplexed Evaluation of Serum and CSF Pharmacokinetics of Brain-Targeting Single-Domain Antibodies Using a NanoLC-SRM-ILIS Method
Arsalan S. Haqqani et al.
MOLECULAR PHARMACEUTICS (2013)
Developing Therapeutic Antibodies for Neurodegenerative Disease
Y. Joy Yu et al.
NEUROTHERAPEUTICS (2013)
Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system
Ana Maria Gonzalez et al.
BMC NEUROSCIENCE (2011)
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Y. Joy Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood-Brain Barrier Delivery in the Mouse
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial Fluid
Xingrong Liu et al.
DRUG METABOLISM AND DISPOSITION (2009)
Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins
Tracey A. Rouault et al.
METABOLIC BRAIN DISEASE (2009)
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
Wolfgang Hoyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Engineering of a femtomolar affinity binding protein to human serum albumin
Andreas Jonsson et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
The blood-brain barrier/neurovascular unit in health and disease
BT Hawkins et al.
PHARMACOLOGICAL REVIEWS (2005)
Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics
DD Shen et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Mechanism for multiple ligand recognition by the human transferrin receptor
AM Giannetti et al.
PLOS BIOLOGY (2003)
Structure, specificity, and mode of interaction for bacterial albumin-binding modules
MU Johansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)